Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPRC | P08575 | 3/20 | 0.52 |
| ▸ | S100A4 | P26447 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | CA7 | P43166 | 1/20 | 0.49 |
| ▸ | CA9 | Q16790 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | BCHE | P06276 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | CES1 | P23141 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29449526 | 1.00 | PTPRC (0.52) | PTPRCS100A4MAPTKDM4EMEN1 | |
| SCHEMBL28626894 | 0.91 | PTGS2 (0.48) | PTPRCS100A4MAPTKDM4EMEN1 | |
| SCHEMBL28088417 | 0.88 | POLB (0.59) | PTPRCS100A4MAPTMEN1KMT2A | |
| SCHEMBL12808481 | 0.87 | MAPT (0.44) | PTPRCS100A4MAPTKDM4EMEN1 | |
| SCHEMBL260788 | 0.86 | CYP1A2 (0.51) | PTPRCS100A4MAPTCA1CA2 | |
| SCHEMBL29367937 | 0.86 | CYP1A2 (0.51) | PTPRCS100A4MAPTCA1CA2 | |
| SCHEMBL5511468 | 0.85 | MAPT (0.45) | PTPRCS100A4MAPTKDM4EMEN1 | |
| SCHEMBL1922592 | 0.82 | GAA (0.56) | MAPTKDM4EMEN1KMT2AMCL1 | |
| SCHEMBL216753 | 0.82 | GPR35 (0.58) | MEN1KMT2ACA1CA2ALDH1A1 | |
| SCHEMBL8832188 | 0.82 | GPR35 (0.58) | MAPTCA1CA2ALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110392725-B | Photoalignment composition for stabilizing pretilt angle in liquid crystal layer | 罗利克技术有限公司 | 2023-12-01 | — | — | CN | disclosed |
| CN-111386493-B | Liquid crystal aligning agent, liquid crystal alignment film, method for producing liquid crystal alignment film, and liquid crystal display element | 日产化学株式会社 | 2023-05-23 | — | — | CN | disclosed |
| US-11561440-B2 | Photoalignment composition for the stabilization of the pre-tilt angle in liquid crystal layers | Rolic Technologies AG (CH) | 2023-01-24 | — | — | US | disclosed |
| US-11561440-B2 | Photoalignment composition for the stabilization of the pre-tilt angle in liquid crystal layers | Rolic Technologies AG (CH) | 2023-01-24 | — | — | US | disclosed |
| CN-113563245-A | Substituted pyrrolidine compounds and application thereof in medicines | 广东东阳光药业有限公司 | 2021-10-29 | — | — | CN | disclosed |
| EP-3628054-B1 | NEW PHOTOALIGNMENT COMPOSITION FOR THE STABILIZATION OF THE PRE-TILT ANGLE IN LIQUID CRYSTAL LAYERS | ROLIC TECH AG (CH) | 2021-10-06 | — | — | EP | disclosed |
| EP-3628054-B1 | NEW PHOTOALIGNMENT COMPOSITION FOR THE STABILIZATION OF THE PRE-TILT ANGLE IN LIQUID CRYSTAL LAYERS | ROLIC TECH AG (CH) | 2021-10-06 | — | — | EP | disclosed |
| CN-108912011-B | Photoalignment material | 罗立克科技股份公司 | 2021-09-24 | — | — | CN | disclosed |
| CN-107011924-B | Photoalignment materials with side substitution | 罗利克有限公司 | 2021-06-01 | — | — | CN | disclosed |
| EP-2534191-B1 | PHOTOALIGNING MATERIAL WITH LATERAL SUBSTITUTION | ROLIC TECH AG (CH) | 2020-04-15 | — | — | EP | disclosed |
| EP-2305632-A1 | Photocrosslinkable materials | Rolic AG (CH) | 2011-04-06 | — | — | EP | disclosed |
| EP-2305631-A1 | Photocrosslinkable materials | Rolic AG (CH) | 2011-04-06 | — | — | EP | disclosed |
| US-20110065859-A1 | THERMALLY STABLE ALIGNMENT MATERIALS | ROLIC AG (CH) | 2011-03-17 | — | — | US | disclosed |
| US-20100048849-A1 | PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP | ROLIC AG (CH) | 2010-02-25 | — | — | US | disclosed |
| WO-2008145225-A2 | PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP | ROLIC AG (CH) | 2008-12-04 | — | — | WO | disclosed |
| US-20080293888-A1 | Photocrosslinkable Materials | ROLIC AG (CH) | 2008-11-27 | — | — | US | disclosed |
| US-20080293888-A1 | Photocrosslinkable Materials | ROLIC AG (CH) | 2008-11-27 | — | — | US | disclosed |
| WO-2008135131-A1 | THERMALLY STABLE ALIGNMENT MATERIALS | ROLIC AG (CH) | 2008-11-13 | — | — | WO | disclosed |
| EP-1860094-A1 | Photocrosslinkable materials | Rolic AG (CH) | 2007-11-28 | — | — | EP | disclosed |
| WO-2007071091-A1 | PHOTOCROSSLINKABLE MATERIALS | ROLIC AG (CH) | 2007-06-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048849-A1 | PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP | DDC, ALAD, DYNC1LI1 | PTPRC 3428/4885S100A4 2447/4885MAPT 1424/4885 |
| US-20080293888-A1 | Photocrosslinkable Materials | DDC, PARG, ALAD | PTPRC 4280/4885S100A4 1614/4885MAPT 295/4885 |
| US-20110065859-A1 | THERMALLY STABLE ALIGNMENT MATERIALS | PARG, PARN, PUF60 | PTPRC 4701/4885S100A4 2123/4885MAPT 159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.